Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines

Present immunoprevention and immunotherapeutic approaches against cancer suffer from the limitation of being not “sterilizing” procedures, as very poor protection against the tumor is obtained. Thus newly conceived anti-tumor vaccination strategies are urgently needed. In this review we will focus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Accolla, Roberto S, Tosi, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478985/
https://www.ncbi.nlm.nih.gov/pubmed/22849661
http://dx.doi.org/10.1186/1479-5876-10-154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478985/
https://www.ncbi.nlm.nih.gov/pubmed/22849661
http://dx.doi.org/10.1186/1479-5876-10-154

Ejemplares similares